FDA Investigator Mohsen Rajabi Abhari, FDA
Mohsen Rajabi Abhari, FDA has conducted inspections on 35 sites in 9 countries as of 02 Mar 2020. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
35
Last Inspection Date:
02 Mar 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
India,
United States of America,
United Kingdom of Great Britain and Northern Ireland,
Canada,
Netherlands,
Germany,
Israel,
Spain,
Switzerland
FDA Investigators that have inspected at least one site in common with Mohsen Rajabi Abhari, FDA:
Ademola O Daramola,
Alan P Kurtzberg,
Alanna L Mussawwir Bias,
Alexander M Kay,
Alia Legaux,
Allen F Hall,
Amalia C Himaya,
Amanda E Lewin, PhD,
Anders W Evenson,
Andrace L Deyampert,
Andrea A Branche,
Anita Narula, PhD,
Anita R Michael,
Anthony E Keller, RPh,
Arindam Dasgupta, PhD,
Barbara Janine Breithaupt,
Barry Cherney, PhD,
Benton M Ketron,
Bichsa T Tran,
Bo Chi, PhD,
Bonita S Chester,
Brandy D Brown,
Brett R Havranek,
Brien C Fox,
Burnell M Henry,
Byungja E Marciante,
Cara M Minelli,
Carl J Montgomery,
Carla J Lundi,
Caryn M Mcnab,
CDR Rochelle B Young, RPh, MSA,
Chaoying C Ma,
Charles R Bonapace, PhD,
Charles R Cote, RIC,
Chase Bourke, PhD,
Cheron M Portee,
Chris A Sack,
Christina C Santos,
Christina V Santos,
Comyar Shoghi,
Corey K Reno,
Courtney N Long,
Craig A Garmendia,
Cynthia L Evitt,
Cynthia White,
Daniel J Lahar,
Daniel J Roberts,
Daniel L Aisen,
Daniel W Cline,
David L Chon,
David M Mcnew,
David R Heiar,
Davinna Ligons, PhD,
Dawn C Olenjack,
Dawn L Wydner,
Denise L Burosh,
Denise M Visco, Investigator,
Diane Cvan Leeuwen,
Dipesh K Shah,
Doan T Nguyen, PharmD,
Donna Ltartaglino Besone,
Douglas A Campbell,
Dr. Abhijit Raha, PhD,
Dr. Carmelo Rosa,
Dr. Gopa Biswas, PhD,
Dr. Sriram Subramaniam, PhD,
Edward D Mcdonald,
Edwin Melendez,
Eileen A Liu,
Eric C Nielsen,
Eric M Mueller, PharmD,
Esther C Broner, PhD,
Farhana Khan,
Felix Maldonado,
Frances Namuswe, PhD,
Gabriel Davila,
Gajendiran Mahadevan, PhD,
Gary T Greco,
Gavin T Cua,
Gene D Arcy,
George C Amedro,
George Ivan Wey,
Gloria E Parra,
Gulshan R Anand,
Haley H Seymour,
Hanna L Potter,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Hector Jcolon Torres,
Himanshu Gupta, PhD,
Iram R Hassan, PhD,
Iris C Macinnes,
Jacob G Lutz,
Jacob W Reynolds,
Jacqueline A O'shaughnessy, PhD,
James M Kewley,
James R Fleckenstein,
Jane E Nelson,
Janete F Guardia,
Jasjeet K Sekhon,
Jean M Kelahan,
Jee Chung, PhD,
Jeffery A Hangartner,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer M Gogley,
Jessica E Hensley,
Jessica L Peterson,
Joanne M Schlossin,
Joel D Martinez,
Joel Welch, PhD,
John A Iwen,
John A Kadavil, PhD,
John R Myung,
John S Hartford,
Jonathan R Campos,
Jonee J Mearns,
Jose A Lopez,
Jose Acruz Gonzalez,
Joseph L Despins, PhD,
Joseph R Lambert,
Junho Pak,
Justin A Boyd,
Jyoti B Patel, PhD,
Ka L Wong,
Kara A Scheibner, PhD,
Karen L Kosar,
Karen M Cooper,
Kathleen R Jones, PhD,
Kathryn A Krentz,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kenneth H Williams,
Kerun Hardeo,
Kevin A Gonzalez,
Kham Phommachanh,
Kim Lthomas Cruse,
Kimberly A Benson,
Kirtida Patel,
Lakecha N Lewis,
Lata C Mathew, PhD,
Latonya M Mitchell,
Laura Fontan, MS,
Laverne Puckett,
LCDR Chad N Thompson,
LCDR Ismael Olvera, IV,
Leonard H Lavi,
Lequita M Mayhew,
Li Hongpaul Yeh, PhD,
Linda M Cheny,
Linda R Kuchenthal,
Linda S Leja,
Linda Thai,
Lori A Gioia,
Lori J Silverstein,
Maan S Abduldayem,
Makini Cobourne Duval, PhD,
Marc R Dickens,
Marcia B Williams,
Marcus F Yambot,
Margaret E Sarles,
Margaret M Annes,
Margaret M Sands,
Martin K Yau, PhD,
Matthew B Casale,
Matthew C Watson,
Maxyne T Lam,
Melkamu Getie Kebtie, PhD,
Michael A Taylor,
Michael F Skelly, PhD,
Michael G Sinkevich,
Michael R Goga,
Michael Serrano,
Michelle A Marsh,
Mihaly S Ligmond,
Mike M Rashti,
Mra M Barbosar,
Mra Mcculloughj,
Muralidhara B Gavini, PhD,
Nancy L Rolli,
Nathan R Moon,
Nerizza B Dalena,
Nerizza B Guerin,
Nicholas C Mendiola,
Nicholas Obiri, PhD,
Nicholas Z Lu,
Nicola M Fenty Stewart,
Nicole M Bell,
Nilufer M Tampal, PhD,
Nina Yang,
Niraj R Mehta, PhD,
Omotunde O Osunsanmi,
Pamela L Velez Vega,
Pankaj H Amin,
Parul M Patel,
Patrick L Wisor,
Paul A Bonneau,
Paul L Bellamy,
Paula J Bretz,
Peter R Lenahan,
Peter S Diak,
Raymond T Oji,
Rebecca Rodriguez,
Richard W Berning,
Richmond K Yip,
Robert C Steyert,
Robert D Tollefsen,
Robert Darius,
Robert J Doyle,
Rodney D Combs,
Roger F Zabinski,
Rona Leblanc, PhD,
Ronald L Koller,
Ronald R Ruff,
Ronda Leblanc,
Ruben C Ayala, PharmD,
Russ E Davis,
Saied A Asbagh,
Sam H Haidar, PhD,
Samantha J Pinizzotto, D V M,
Sandra A Hughes,
Sandra S Saniga,
Sarah Arden,
Sarah E Rhoades,
Scott B Laufenberg,
Scott R Nichols, PhD,
Seongeun Cho (Julia), PhD,
Sherri N Rohlf, MD,
Shirley J Berryman,
Sidney B Priesmeyer,
Simone E Pitts,
Sonia R Peterson,
Sripal R Mada, PhD,
Stacey S Degarmo,
Stanley Au,
Stephanie Mangigian, MS/OSH, RN,
Stephen D Brown,
Steven Fong, MS, PhD,
Steven M Weinman,
Steven P Donald,
Sunitha K Rajaram, PhD,
Susan D Yuscius,
Susanna E Ford,
Susanne M Richardson, MS RAC,
Taichun Qin, PhD,
Tamika White,
Tawny L Colling,
Terri L Dodds,
Thao T Kwan,
Thao X Tran,
Thea C Grome,
Theressa B Smith,
Thomas W Nojek,
Timothy C Grome,
Timothy T Kapsala,
Torrance J Slayton,
Tracey L Harris,
Traci C Kelm,
Uttaniti Limchumroon (Tom),
Vickie J Kanion,
Vlada Matusovsky,
Wayne T Smith,
Xiaohan Cai, PhD,
Xikui Chen (nmi), PhD,
Yanming An, PhD,
Yiying E Chen,
Yiyue Zhang (nmi), PhD,
Young M Choi, PhD,
Yumi J Hiramine,
Yvonne C Wilkes,
Zachary A Bogorad
Mohsen Rajabi Abhari, FDA's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2017 | EIR | Intertek USA, Inc. - EIR, 2017-11-09 |
December, 2016 | FDA 483 | QPS, LLC - Form 483, 2016-12-16 |
April, 2019 | EIR | PPD Development, L.P. - EIR, 2019-04-26 |
December, 2017 | FDA 483 | Celerion, Inc - Form 483, 2017-12-08 |
November, 2017 | FDA 483 | Intertek USA, Inc. - Form 483, 2017-11-09 |
February, 2017 | FDA 483 | Amgen, Inc - Form 483, 2017-02-17 |
May, 2018 | EIR | PPD Development, L.P. - EIR, 2018-05-18 |
May, 2018 | FDA 483 Response | PPD Development, L.P. - Form 483R, 2018-06-05 |
May, 2018 | FDA 483 | PPD Development, L.P. - Form 483, 2018-05-18 |
August, 2015 | FDA 483 | Eurofins Pharma Bioanalytics Services US Inc. - Form 483, 2015-08-21 |
March, 2017 | FDA 483 | ICON Development Solutions, LLC - Form 483, 2017-03-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more